Commercially available tests for determining cefiderocol susceptibility display variable performance in the Achromobacter genus

Abstract Background Cefiderocol is a siderophore-conjugated cephalosporin increasingly used in the management of Achromobacter infections. Testing for cefiderocol susceptibility is challenging with distinct recommendations depending on the pathogens. Objectives We evaluated the performance of commer...

詳細記述

書誌詳細

主要な著者:	Vincent Jean-Pierre, Pauline Sorlin, Katy Jeannot, Raphaël Chiron, Jean-Philippe Lavigne, Alix Pantel, Hélène Marchandin
フォーマット:	Artigo
言語:	Inglês
出版事項:	BMC 2024-08-01
シリーズ:	Annals of Clinical Microbiology and Antimicrobials
主題:	Cefiderocol Achromobacter Susceptibility testing Microdilution Disk Diffusion
オンライン･アクセス:	https://doi.org/10.1186/s12941-024-00731-1
タグ:	タグ追加 タグなし, このレコードへの初めてのタグを付けませんか!